☆ 4.7 Letter

Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis

CHEST (2021)

期刊

CHEST

卷 160, 期 6, 页码 2158-2162

出版社

ELSEVIER

DOI: 10.1016/j.chest.2021.06.014

关键词

类别

Critical Care Medicine Respiratory System

向作者/读者索取更多资源

Protocol

社区支持

Reagent

社区支持

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

主要评分

4.7

评分不足

次要评分

新颖性

重要性

科学严谨性

评价这篇论文

Association between gastroprotective agents and risk of incident interstitial lung disease in systemic sclerosis

Raphael Hurtubise, Marie Hudson, Genevieve Gyger, Mianbo Wang, Russell J. Steele, Murray Baron, Sabrina Hoa

Summary: In this large retrospective cohort study, the use of gastroprotective or promotility agents was not associated with a reduced risk of development of clinically apparent SSc-ILD.

RESPIRATORY MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Association between Appendicitis and Incident Systemic Sclerosis

Kuang-Tsu Yang, James Cheng-Chung Wei, Renin Chang, Chi-Chien Lin, Hsin-Hua Chen

Summary: This nationwide study revealed an association between newly diagnosed systemic sclerosis and previous history of appendicitis. Furthermore, the risk of developing SSc was also significantly associated with Charlson comorbidity index >=1 and periodontal disease.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Rheumatology

Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study

Qiang Li, Laura Wallace, Padmaja Patnaik, Margarida Alves, Martina Gahlemann, Veronika Kohlbrenner, Christina Raabe, Jocelyn R. Wang, Elizabeth M. Garry

Summary: The study found low prevalence estimates and incidence rates for SSc and SSc-ILD in the US, with newly diagnosed SSc-ILD patients receiving more immunosuppressive therapy and having more comorbidities compared to newly diagnosed SSc patients.

RHEUMATOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Association between Routine Laboratory Parameters and the Severity and Progression of Systemic Sclerosis

Liticia Chikhoune, Thierry Brousseau, Sandrine Morell-Dubois, Meryem Maud Farhat, Helene Maillard, Emmanuel Ledoult, Marc Lambert, Cecile Yelnik, Sebastien Sanges, Vincent Sobanski, Eric Hachulla, David Launay

Summary: This study aimed to assess the association of routine laboratory parameters with the severity and progression of systemic sclerosis (SSc). The results showed that certain routine laboratory parameters were associated with different clinical presentations and outcomes of SSc.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

Association Between Lipid Profile and Risk of Incident Systemic Sclerosis: A Nationwide Population-Based Study

Oh Chan Kwon, Kyungdo Han, Min-Chan Park

Summary: In this study, we found that levels of total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol were inversely associated with the risk of incident systemic sclerosis (SSc). These findings suggest that these lipid levels could be considered as potential markers for detecting individuals at high risk of incident SSc.

CLINICAL EPIDEMIOLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Characteristics and risk factors of mortality in patients with systemic sclerosis-associated interstitial lung disease

Hye Jin Jang, Ala Woo, Song Yee Kim, Seung Hyun Yong, Youngmok Park, Kyungsoo Chung, Su Hwan Lee, Ah Young Leem, Sang Hoon Lee, Eun Young Kim, Ji Ye Jung, Young Ae Kang, Young Sam Kim, Moo Suk Park

Summary: This study aimed to identify risk factors for mortality and compare the clinical characteristics of patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD). The study found that approximately 10% of SSc-ILD patients showed disease progression, and ILD was detected within less than five years from the first visit. Therefore, careful monitoring of symptoms and signs from an early stage and long-term surveillance are necessary.

ANNALS OF MEDICINE (2023)

添加到收藏夹

Article Dermatology

Serum S100A12 levels: Possible association with skin sclerosis and interstitial lung disease in systemic sclerosis

Jun Omatsu, Ryosuke Saigusa, Takuya Miyagawa, Yuki Fukui, Satoshi Toyama, Kentaro Awaji, Tetsuya Ikawa, Yuta Norimatsu, Ayumi Yoshizaki, Shinichi Sato, Yoshihide Asano

Summary: The expression levels of S100A12 are significantly elevated in systemic sclerosis (SSc) patients, especially in lesional skin and bulk skin. Serum S100A12 levels are correlated with the severity of skin involvement and the presence of interstitial lung disease in SSc patients.

EXPERIMENTAL DERMATOLOGY (2021)

添加到收藏夹

Article Rheumatology

Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease

Cosimo Bruni, Mariaelena Occhipinti, Michael Pienn, Gianna Camiciottoli, Maurizio Bartolucci, Silvia Laura Bosello, Christian Payer, Zoltan Balint, Anna Rita Larici, Alessandra Tottoli, Lorenzo Tofani, Enrico De Lorenzis, Gemma Lepri, Silvia Bellando-Randone, Amelia Spinella, Dilia Giuggioli, Francesco Masini, Giovanna Cuomo, Federico Lavorini, Stefano Colagrande, Horst Olschewski, Marco Matucci-Cerinic

Summary: Recent advancements have made it possible to quantitatively assess lung vascular and parenchymal changes in thoracic CT images using automated software tools. In this study, the researchers investigated the vessel parameters of patients with SSc and correlated them with interstitial lung disease (ILD) features. The results showed that the CT vessel parameters increased in parallel with ILD extent and functional impairment, suggesting that they may serve as a biomarker of SSc-ILD severity.

RHEUMATOLOGY (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Interstitial Lung Disease in Systemic Lupus Erythematosus and Systemic Sclerosis: How Can We Manage the Challenge?

Patricia Richter, Anca Cardoneanu, Nicoleta Dima, Ioana Bratoiu, Ciprian Rezus, Alexandra Maria Burlui, Damiana Costin, Luana Andreea Macovei, Elena Rezus

Summary: Interstitial lung disease (ILD) is a serious manifestation of connective tissue diseases (CTD) that requires thorough evaluation and treatment. The prevalence of ILD in systemic lupus erythematosus (SLE) is still debated, but it is crucial to exclude an overlap syndrome for an accurate diagnosis. Increasing the identification of SLE-associated ILD cases is important, and various treatment options are being proposed. Systemic sclerosis (SSc)-associated ILD is a leading cause of mortality and should be investigated in all SSc patients. Progress has been made in the treatment of ILD, with tyrosine kinases inhibitor Nintedanib showing promising results in reducing the progression rate compared to placebo.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Rheumatology

Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease

David Roofeh, Kevin K. Brown, Ella A. Kazerooni, Donald Tashkin, Shervin Assassi, Fernando Martinez, Athol U. Wells, Ganesh Raghu, Christopher P. Denton, Lorinda Chung, Anna-Maria Hoffmann-Vold, Oliver Distler, Kerri A. Johannson, Yannick Allanore, Eric L. Matteson, Leticia Kawano-Dourado, John D. Pauling, James R. Seibold, Elizabeth R. Volkmann, Simon L. F. Walsh, Chester Oddis, Eric S. White, Shaney L. Barratt, Elana J. Bernstein, Robyn T. Domsic, Paul F. Dellaripa, Richard Conway, Ivan Rosas, Nitin Bhatt, Vivien Hsu, Francesca Ingegnoli, Bashar Kahaleh, Puneet Garcha, Nishant Gupta, Surabhi Khanna, Peter Korsten, Celia Lin, Stephen C. Mathai, Vibeke Strand, Tracy J. Doyle, Virginia Steen, Donald F. Zoz, Juan Ovalles-Bonilla, Ignasi Rodriguez-Pinto, Padmanabha D. Shenoy, Andrew Lewandoski, Elizabeth Belloli, Alain Lescoat, Vivek Nagaraja, Wen Ye, Suiyuan Huang, Toby Maher, Dinesh Khanna

Summary: This study aimed to establish a framework by which experts define disease subsets in systemic sclerosis associated interstitial lung disease (SSc-ILD). The results showed that using the proposed conceptual framework, international experts were able to achieve a consensus on classifying SSc-ILD patients along the dimensions of disease severity, risk of progression and progression over time.

RHEUMATOLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Serum TARC Levels in Patients with Systemic Sclerosis: Clinical Association with Interstitial Lung Disease

Ai Kuzumi, Ayumi Yoshizaki, Satoshi Ebata, Takemichi Fukasawa, Asako Yoshizaki-Ogawa, Yoshihide Asano, Koji Oba, Shinichi Sato

Summary: The study found that serum TARC levels were elevated in SSc patients, especially in those with the diffuse subtype and SSc-associated ILD. However, there was no significant correlation between serum TARC levels with pulmonary function and serum levels of interleukin-13. Longitudinal study showed that serum TARC levels did not predict the onset or progression of SSc-ILD in patients with SSc.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Treatment and Systemic Sclerosis Interstitial Lung Disease Outcome: The Overweight Paradox

Alexandra Nagy, Erik Palmer, Lorinc Polivka, Noemi Eszes, Krisztina Vincze, Eniko Barczi, Aniko Bohacs, Adam Domonkos Tarnoki, David Laszlo Tarnoki, Gyoergy Nagy, Emese Kiss, Pal Maurovich-Horvat, Veronika Mueller

Summary: This study evaluated the clinical characteristics and predictors of lung function changes in SSc-ILD patients treated in a real-world setting. The results showed that untreated patients had the most prominent functional decline, and a normal body mass index was associated with a significant risk of deterioration. The majority of patients improved or were stable during follow-up.

BIOMEDICINES (2022)

添加到收藏夹

Article Health Care Sciences & Services

Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis

Chiara Pellicano, Marzia Miglionico, Laura Romaggioli, Amalia Colalillo, Lorenzo Vantaggio, Cecilia Napodano, Cinzia Calla, Francesca Gulli, Mariapaola Marino, Umberto Basile, Edoardo Rosato

Summary: This study found that SSc patients have increased levels of CH50 and serum C2 compared to healthy controls. These findings may be associated with disease severity and the severity of skin and lung fibrosis in SSc patients.

JOURNAL OF PERSONALIZED MEDICINE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Emerging Evidence and Treatment Perspectives from Randomized Clinical Trials in Systemic Sclerosis: Focus on Interstitial Lung Disease

Caterina Oriana Aragona, Antonio Giovanni Versace, Carmelo Ioppolo, Daniela La Rosa, Rita Lauro, Maria Concetta Tringali, Simona Tomeo, Guido Ferlazzo, William Neal Roberts, Alessandra Bitto, Natasha Irrera, Gianluca Bagnato

Summary: This review discusses recent advancements in the treatment of systemic sclerosis-associated interstitial lung disease, including new molecular targets and approved drugs to slow disease progression. The focus is on personalized treatment strategies based on emerging pathogenic features of the disease.

BIOMEDICINES (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis

Joe E. Mouawad, Carol Feghali-Bostwick

Summary: Systemic sclerosis, also known as scleroderma, is an autoimmune disorder that affects the connective tissues and has a high mortality rate. Fibrosis, particularly in the lungs, is a hallmark of the disease and is currently the leading cause of death. Understanding the molecular mechanisms involved in lung fibrosis is essential for developing potential therapies to improve patient outcomes and quality of life.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Editorial Material Rheumatology

COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

Michael Putman, Kevin Kennedy, Emily Sirotich, Jean W. Liew, Sebastian E. Sattui, Tarin T. Moni, Akpabio A. Akpabio, Deshire Alpizar-Rodriguez, Saskya Angevare, Richard P. Beesley, Francis Berenbaum, Inita Bulina, Yu Pei Eugenia Chock, Richard Conway, Ali Duarte-Garcia, Aman Dev Singh, Eimear Duff, Karen L. Durrant, Tamer A. Gheita, Catherine L. Hill, Richard Howard, Bimba F. Hoyer, Evelyn Hsieh, Lina el Kibbi, Adam Kilian, Alfred H. J. Kim, David F. L. Liew, Chieh Lo, Elsa F. Mateus, Bruce Miller, Serena Mingolla, Michal Nudel, Jasvinder A. Singh, Namrata Singh, Manuel F. Ugarte-Gil, John Wallace, Kristen J. Young, Erick Adrian Zamora-Tehozol, Suleman Bhana, Wendy Costello, Rebecca Grainger, Pedro M. Machado, Philip C. Robinson, Paul Sufka, Zachary S. Wallace, Jinoos Yazdany, Carly Harrison, Maggie J. Larche, Mitchell Levine, Gary Foster, Lehana Thabane, Jonathan S. Hausmann, Jeffrey A. Sparks, Julia F. Simard

LANCET RHEUMATOLOGY (2022)

添加到收藏夹

Article Rheumatology

Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey

Lisa G. Rider, Christine G. Parks, Jesse Wilkerson, Adam Schiffenbauer, Richard K. Kwok, Payam Noroozi Farhadi, Sarvar Nazir, Rebecca Ritter, Emily Sirotich, Kevin Kennedy, Maggie J. Larche, Mitchell Levine, Sebastian E. Sattui, Jean W. Liew, Carly O. Harrison, Tarin T. Moni, Aubrey K. Miller, Michael Putman, Jonathan Hausmann, Julia F. Simard, Jeffrey A. Sparks, Frederick W. Miller

Summary: The study found that disease flares requiring changes in treatment after COVID-19 vaccination were uncommon among patients with systemic rheumatic diseases. Certain SRD types like systemic lupus erythematosus, psoriatic arthritis, and polymyalgia rheumatica were associated with higher odds of flare, while idiopathic inflammatory myopathies were associated with lower odds. The Oxford-AstraZeneca vaccine, a prior reaction to a non-COVID-19 vaccine, and female sex were identified as potential risk factors for disease flares following vaccination.

RHEUMATOLOGY (2022)

添加到收藏夹

Article Rheumatology

Damage Trajectories in Systemic Sclerosis Using Group-Based Trajectory Modeling

Ariane Barbacki, Murray Baron, Mianbo Wang, Yuqing Zhang, Wendy Stevens, Joanne Sahhar, Susanna Proudman, Mandana Nikpour, Ada Man

Summary: This study found distinct trajectories of damage accrual in patients with systemic sclerosis, with age, gender, disease type, tendon friction rubs, and C-reactive protein level being associated with the different trajectories. These findings may be helpful in identifying patients who require early aggressive treatment.

ARTHRITIS CARE & RESEARCH (2023)

添加到收藏夹

Article Rheumatology

Health Care Utilization in Systemic Sclerosis Patients With Digital Ulcers

Tatiana Nevskaya, Leonardo M. Calderon, Murray Baron, Janet E. Pope

Summary: Digital ulcers in systemic sclerosis patients lead to increased utilization of healthcare resources, including tests, visits, and aids. Even after adjusting for disease severity in other organ systems, the presence of digital ulcers remains a significant predictor of more frequent physician visits and more tests.

ARTHRITIS CARE & RESEARCH (2023)

添加到收藏夹

Article Rheumatology

Validation of the parent global assessment as a health-related quality of life measure in juvenile idiopathic arthritis: results from ReACCh-Out

Kiem Oen, Karine Toupin-April, Brian M. Feldman, Roberta A. Berard, Cia'ran M. Duffy, Lori B. Tucker, Jiahao Tian, Dax G. Rumsey, Jaime Guzman

Summary: This study validates the JIA parent global assessment as a valid measure of health-related quality of life. Comparisons with other HRQoL measures show good construct validity. However, reliability estimates and measurement errors were unsatisfactory, likely due to the time interval between assessments. Causal pathway analysis confirms previous findings.

RHEUMATOLOGY (2023)

添加到收藏夹

Article Rheumatology

Effect of pregnancy on scleroderma progression

Siobhan Deshauer, Mats Junek, Murray Baron, Karen A. Beattie, Margaret J. Larche

Summary: This study examined the impact of pregnancy on disease activity in women with systemic sclerosis. The results showed that having at least one pregnancy after diagnosis did not significantly affect long-term renal, respiratory, or global function outcomes. However, postpartum complications should still be monitored.

JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort

Mohammad Movahedi, Angela Cesta, Xiuying Li, Claire Bombardier

Summary: This study described the disease activity trajectories in early and established rheumatoid arthritis (RA). The findings showed better treatment outcomes in early RA compared to established RA, and demonstrated the impact of sociodemographic characteristics and early treatment on disease course.

PLOS ONE (2022)

添加到收藏夹

Article Rheumatology

Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

Michael DiIorio, Kevin Kennedy, Jean W. Liew, Michael S. Putman, Emily Sirotich, Sebastian E. Sattui, Gary Foster, Carly Harrison, Maggie J. Larche, Mitchell Levine, Tarin T. Moni, Lehana Thabane, Suleman Bhana, Wendy Costello, Rebecca Grainger, Pedro M. Machado, Philip C. Robinson, Paul Sufka, Zachary S. Wallace, Jinoos Yazdany, Monique Gore-Massy, Richard A. Howard, More A. Kodhek, Nadine Lalonde, Laura-Ann Tomasella, John Wallace, Akpabio Akpabio, Deshire Alpizar-Rodriguez, Richard P. Beesley, Francis Berenbaum, Inita Bulina, Eugenia Yupei Chock, Richard Conway, Ali Duarte-Garcia, Eimear Duff, Tamer A. Gheita, Elizabeth R. Graef, Evelyn Hsieh, Lina El Kibbi, David F. L. Liew, Chieh Lo, Michal Nudel, Aman Dev Singh, Jasvinder A. Singh, Namrata Singh, Manuel F. Ugarte-Gil, Jonathan S. Hausmann, Julia F. Simard, Jeffrey A. Sparks

Summary: This study investigated the prolonged COVID-19 symptom duration among people with systemic autoimmune rheumatic diseases (SARDs). The results showed that approximately one in four patients experienced symptoms lasting 28 days or longer, and about one in ten experienced symptoms lasting 90 days or longer.

RMD OPEN (2022)

添加到收藏夹

Article Rehabilitation

A qualitative interview study exploring the psychological health impacts of the SPIN-CHAT program among people with systemic sclerosis at the onset of COVID-19: perceptions of trial participants and research team members

Amanda Wurz, Delaney Duchek, Kelsey Ellis, Mannat Bansal, Marie-Eve Carrier, Lydia Tao, Laura Dyas, Linda Kwakkenbos, Brooke Levis, Ghassan El-Baalbaki, Danielle B. Rice, Yin Wu, Richard S. Henry, Laura Bustamante, Sami Harb, Shannon Hebblethwaite, Scott B. Patten, Susan J. Bartlett, John Varga, Luc Mouthon, Sarah Markham, Brett D. Thombs, S. Nicole Culos-Reed

Summary: This study explored the impact of the videoconference-based supportive care program (SPIN-CHAT program) on individuals with systemic sclerosis (SSc) during early COVID-19. Interviews with trial participants and research team members revealed that the program had positive effects on psychological health, provided SSc-specific support, created a safe space for group interaction, reduced boredom, and offered self-management skills.

DISABILITY AND REHABILITATION (2023)

添加到收藏夹

Article Rheumatology

Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM

Sofia Ramiro, Robert Landewe, Desiree van der Heijde, Alexandre Sepriano, Oliver FitzGerald, Mikkel Ostergaard, Joanne Homik, Ori Elkayam, J. Carter Thorne, Maggie J. Larche, Gianfranco Ferraccioli, Marina Backhaus, Gilles Boire, Bernard Combe, Thierry Schaeverbeke, Alain Saraux, Maxime Dougados, Maurizio Rossini, Marcello Govoni, Luigi Sinigaglia, Alain G. Cantagrel, Cornelia F. Allaart, Cheryl Barnabe, Clifton O. Bingham III, Dirkjan van Schaardenburg, Hilde B. Hammer, Rana Dadashova, Edna Hutchings, Joel Paschke, Walter P. Maksymowych

Summary: The study investigates whether meticulously following a treat-to-target (T2T) strategy in daily clinical practice leads to less radiographic progression in patients with active rheumatoid arthritis (RA). The findings show that a more stringent application of T2T does not result in less radiographic progression compared to a somewhat lenient attitude towards T2T.

RHEUMATOLOGY (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Randomized controlled trial of an internet-based self-guided hand exercise program to improve hand function in people with systemic sclerosis: the Scleroderma Patient-centered Intervention Network Hand Exercise Program (SPIN-HAND) trial

Linda Kwakkenbos, Marie-Eve Carrier, Joep Welling, Brooke Levis, Alexander Levis, Maureen Sauve, Kimberly Turner, Lydia Tao, Kylene Aguila, Andrea Carboni-Jimenez, Mara Canedo-Ayala, Sami Harb, Cornelia van den Ende, Marie Hudson, Ward van Breda, Christelle Nguyen, Isabelle Boutron, Francois Rannou, Brett Thombs, Luc Mouthon

Summary: This study examined the effects of an online self-guided hand exercise program on hand function and functional health outcomes in patients with systemic sclerosis. The results showed that the program did not improve hand function. Low uptake and usage rates limited the assessment of the program's effectiveness. Further testing could be done in a group format or as a resource to support care provided by therapists.

TRIALS (2022)

添加到收藏夹

Article Rheumatology

Validity, Reliability, and Differential Item Functioning of English and French Versions of the 10-Item Connor-Davidson Resilience Scale in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study

Marieke S. Neyer, Richard Henry, Marie-Eve Carrier, Linda K. Kwakkenbos, Robyn Wojeck, Amy Gietzen, Karen Gottesman, Genevieve Guillot, Amanda D. Lawrie-Jones, Maureen Mayes, Luc R. Mouthon, Warren Nielson, Michelle Richard, Maureen Worron-Sauve, Daphna L. Harel, Vanessa J. Malcarne, Susan D. Bartlett, Brett Thombs

Summary: The study aimed to evaluate the validity, reliability, and differential item functioning (DIF) of the 10-item Connor-Davidson Resilience Scale (CD-RISC-10) in systemic sclerosis (SSc) patients between the English and French versions. The results showed that the CD-RISC-10 is a valid and reliable measure of resilience in SSc, with score comparability between the English and French versions.

ARTHRITIS CARE & RESEARCH (2023)

添加到收藏夹

Article Rheumatology

Evaluation of Measurement Properties and Differential Item Functioning in the English and French Versions of the University of California, Los Angeles, Loneliness Scale-6: A Scleroderma Patient-Centered Intervention Network (SPIN) Study

Chelsea S. Rapoport, Alyssa Choi, Linda S. Kwakkenbos, Marie-Eve Carrier, Richard C. Henry, Luc D. Mouthon, Scott L. Roesch, Brett Thombs, Vanessa Malcarne

Summary: This study examined and compared the psychometric properties of the English and French versions of the University of California, Los Angeles, Loneliness Scale-6 (ULS-6) in patients with systemic sclerosis (SSc). The results showed that ULS-6 had acceptable reliability and validity in both English and French-speaking adults with SSc.

ARTHRITIS CARE & RESEARCH (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Evidence of a Novel Mitochondrial Signature in Systemic Sclerosis Patients with Chronic Fatigue Syndrome

Charmaine van Eeden, Desiree Redmond, Naima Mohazab, Maggie J. J. Larche, Andrew L. L. Mason, Jan Willem Cohen Tervaert, Mohammed S. S. Osman

Summary: This study aimed to assess the prevalence of ME/CFS in early limited cutaneous systemic sclerosis (lcSSc) patients and determine if alterations in mitochondrial gene expression and mtDNA integrity could be used to distinguish between fatigued and non-fatigued patients. ME/CFS-related symptoms were assessed through questionnaires, and the expression of mitochondrial gene transcripts and mtDNA integrity were quantified. The study found that SSc patients with ME/CFS could be differentiated from non-fatigued patients through mitochondrial gene analysis, specifically with reduced expression of ND4 and CyB and increased expression of Cox7C. ND4 and CyB expression were also correlated with disease severity indicators.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Medicine, General & Internal

Patterns of patient-reported symptoms and association with sociodemographic and systemic sclerosis disease characteristics: a scleroderma Patient-centered Intervention Network (SPIN) Cohort cross-sectional study

Robyn K. Wojeck, Mitchell R. Knisely, Donald E. Bailey, Tamara J. Somers, Linda Kwakkenbos, Marie -Eve Carrier, Warren R. Nielson, Susan J. Bartlett, Vanessa L. Malcarne, Marie Hudson, Brooke Levis, Andrea Benedetti, Luc Mouthon, Brett D. Thombs, Susan G. Silva, SPIN Investigator

Summary: This study aimed to identify classes of individuals with similar symptom clusters in systemic sclerosis and evaluate associated characteristics. The majority of systemic sclerosis patients showed consistency between symptom levels and sociodemographic and disease-related variables. However, there was a group with low mental health symptoms despite high levels of other symptoms. This study highlights the importance of developing coping strategies and improving quality of life for systemic sclerosis patients.

ECLINICALMEDICINE (2023)

添加到收藏夹

暂无数据

Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis

期刊

出版社

ELSEVIER

关键词

类别

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

评论

主要评分

次要评分

新颖性

重要性

科学严谨性

评价这篇论文

推荐

导出引文

分享论文